Flash Sale! to get a free eCookbook with our top 25 recipes.

Cosmetic thread market set for strong growth through 2035

Cosmetic thread market set for strong growth through 2035

The global cosmetic thread market is expected to nearly double by 2035, reaching USD 1,475.4 million from USD 750 million in 2025. Analysts report a 7.0 per cent CAGR, highlighting the growing preference for minimally invasive aesthetic procedures. Patients increasingly prefer natural-looking results over surgical facelifts, boosting demand for high-precision thread treatments.

PDO threads dominate the market


Polydioxanone (PDO) threads hold a 60 per cent market share due to safety and predictable absorption. PDO threads provide effective skin lifting without anaesthesia or long recovery times. The market’s first growth phase, 2025–2030, anticipates revenue reaching USD 1,065 million as dermatology clinics and medical spas adopt thread lifts.

Advanced materials drive innovation


Poly-L-Lactic Acid (PLLA) and Polycaprolactone (PCL) threads are gaining popularity. They stimulate collagen production more effectively and offer longer-lasting results. Combination therapies, pairing thread lifts with botulinum toxins, fillers, and energy-based devices, are becoming standard among practitioners.

Medical tourism fuels regional growth


India leads with a 9.5% CAGR, supported by expanding aesthetic clinics and international patient inflow in Mumbai and Delhi. China follows at 8.5% CAGR, focusing on high-end thread systems in Shanghai and Beijing. South Korea maintains a 7.2% CAGR and continues to innovate advanced lifting techniques and digital aesthetic platforms.

Market consolidation favors top players


The top five companies capture 60–65% of revenue. Success depends on creating practitioner ecosystems with certification programs, hands-on training, and posttreatment support. Leading companies include Aptos, Croma Pharma, Sinclair Pharma, N-Finders, Intraline, Metro Korea, Healux, HansBiomed, NovaThreads, Aesthetic Experts Lab, PromoItalia, Zimmer Aesthetics, Regen Biotech, MINT PDO, and Samyang Biopharm.

Shift from trend-driven to value-based growth


Analysts note that thread lifting is moving from niche to standard treatments in dermatology and plastic surgery centres. Companies that emphasise biocompatible innovation and practitioner education gain strong market loyalty. Demand for preconfigured treatment protocols and follow-up care products is also rising.

Market outlook remains positive


The cosmetic thread market reflects broader trends in regenerative aesthetics. Consumers prefer minimally invasive procedures that enhance appearance naturally. Technological innovation, training, and expanding medical tourism continue to shape market dynamics. Analysts predict consistent growth, making cosmetic threads a staple in modern aesthetic practices by 2035.